Company Name

Industry

Location

Revenue

Employees

Mariana Oncology

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Rectify Pharma

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Orbital Therapeutics

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Cellorama

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

CAMP4 Therapeutics

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Vaccine and Immunotherapy Center

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Larkspur Biosciences

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Paragon Therapeutics

Biotechnology

United States, Massachusetts

$250M to $500M

11-50

Spero Therapeutics

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

Arc Bio

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

FerGene

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

AIRNA

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

KALA BIO

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

Directed Genomics

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

N2 Biomedical

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

Abiologics

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

Matterworks

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

Precede Biosciences

Biotechnology

United States, Massachusetts

$100M to $250M

11-50

Gelesis

Biotechnology

United States, Massachusetts

$50M to $100M

11-50

Cygnal Therapeutics

Biotechnology

United States, Massachusetts

$50M to $100M

11-50